F-star Therapeutics, Inc.
FSTXNASDAQHealthcare
$7.12
+$0.00(+0.00%)
Market Cap$156511128
P/E Ratio—
52W High$7.12
52W Low$2.07
F-star Therapeutics, Inc.（FSTX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · FSTX · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2021-12 | 2020-12 | 2019-12 | 2018-12 | 2017-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $21.17M | $11.26M | $28.32M | $0.00M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $21.17M | $11.26M | $28.32M | $0.00M | $0.00M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | — | — |
| Operating Expenses | |||||
| R&D Expenses | $28.75M | $14.13M | $31.39M | $19.75M | $13.07M |
| G&A Expenses | $23.13M | $19.51M | $15.28M | $8.72M | $8.18M |
| Total Operating Expenses | $51.88M | $33.64M | $46.67M | $28.47M | $21.25M |
| Operating Income | ($30.71M) | ($22.39M) | ($22.50M) | ($28.47M) | ($21.25M) |
| Operating Margin %(computed) | -145.10% | -198.87% | -79.44% | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $1.00M | $0.37M |
| Interest Expense | $0.84M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | ($31.66M) | ($25.62M) | ($23.75M) | ($22.85M) | ($27.68M) |
| Income Tax Expense | ($0.37M) | ($0.00M) | ($0.74M) | $0.00M | $0.00M |
| Net Income | ($31.28M) | ($25.62M) | ($23.01M) | ($22.85M) | ($27.68M) |
| Net Margin %(computed) | -147.79% | -227.60% | -81.26% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.88 | $-2.82 | $-2.54 | $-1.60 | $-2.50 |
| Wtd Avg Shares | 16.65M | 9.09M | 9.07M | 14.62M | 11.15M |
| EBITDA | ($29.42M) | ($21.24M) | ($13.35M) | ($28.47M) | ($21.25M) |
| EBITDA Margin %(computed) | -138.99% | -188.71% | -47.13% | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解F-star Therapeutics, Inc.
关于F-star Therapeutics, Inc.（FSTX）损益表
F-star Therapeutics, Inc.（FSTX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2021财年，FSTX实现营收$0.02B，毛利润$0.02B（毛利率100.00%），净利润($0.03B)（净利率-147.79%）。
常见问题
FSTX · 4 问F-star Therapeutics, Inc.（FSTX）2021财年营收为$0.02B，同比up88.1%。
FSTX revenueFSTX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09